Free Online CME

CONTACT INFORMATION
Print this Content

Uveitis Update

 

April 20, 2013

 

James P. Storer Conference Room, 1st Floor
Cole Eye Institute
Cleveland, Ohio

 

Register Online Today

 

Description

This course will review the latest treatment modalities in uveitis including the intravitreal delivery systems for long acting and short acting steroids and the various anti-tumor necrosis factor alpha agents. We will compare these new treatments to the currently accepted systemic immunosuppression regimens with steroids and non- steroidal immunosuppressive therapy. Updates on infectious uveitis syndromes will be presented. Case presentations with emphasis on audience interaction will provide insight on how to conduct a uveitis work up and how to treat various syndromes.

Back to Top

 

Target Audiences

General Ophthalmologists, Uveitis and Vitreoretinal Specialists, Optometrists, Internists, Rheumatologists, Pulmonary and Paramedical Personnel

Back to Top

 

Learning Objectives

At the conclusion of this course, participantswill be able to:

  1. Describe the use of nonspecific drugs including immunosuppressive therapy.
  2. Describe current clinical trials in ocular inflammatory diseases.
  3. Identify newer therapies for non-infectious posterior uveitis syndromes.
  4. Discuss evaluation and treatment of patients with uveitis.

Back to Top

 

Course Directors

Careen Y. Lowder, MD, PhD
Uveitis Service
Cole Eye Institute
Sunil K. Srivastava, MD
Vitreoretinal and Uveitis Service
Cole Eye Institute

Back to Top

 

General Information

Location:
Cole Eye Institute
James P. Storer Conference Room, 1st Floor
E. 105th & Euclid Avenue
Cleveland, OH


For More Information:
Jane Sardelle, sardelj@ccf.org
or 216.444.2010

Back to Top

 

Online Registration/Fees

 

Register Online Today

 

Category Fee
Physician $100
Non-Physician Complimentary

Cleveland Clinic (CCF) and Cleveland Clinic Health System (CCHS) Employees Register by Clicking the Button Below

 

Register Online Today

Back to Top